This Application claims the benefit of PCT Application No. PCT/AU2009/000550 filed on Apr. 30, 2009, entitled “A FLUSHABLE INJECTION PORT,” which claims the benefit of Australian Provisional Application No. 2008903153 filed on Jun. 20, 2008, which are commonly assigned with the present invention and incorporated herein by reference.
The present invention relates to injection ports to deliver a medication to a patient via an intravenous tubing set that includes a length of tubing extending to a needle that is implanted in the patient. A typical example of this arrangement is described in U.S. Pat. No. 5,782,816.
In certain hospitals the above discussed arrangement requires the health care professional involved to use a small saline vial to flush the injection site to ensure that all medication is delivered to the patient. If not flushed, the residual medication is wasted not only from an expense point of view but also from a patient care point of view.
The above discussed arrangement of flushing the injection site has the disadvantage that the healthcare professional must not only provide a vial but is also required to undertake further steps when delivering medication through an injection port. This increases the cost of delivering medication as well as the taken time to flush the site. A further disadvantage is the increased risk of infection due to the changing of connections.
It is the object of the present invention to overcome or substantially ameliorate at least one of the above disadvantages.
There is disclosed herein in combination a burette, a tube to connect the burette to a reservoir containing a first liquid, and an injection port:
said burette having an outlet via which an outward liquid is to be delivered to a patient, an inlet via which said tube delivers the first liquid to said burette;
said tube having an end portion for connection to the reservoir to provide for draining of the first liquid from the reservoir; and
said injection port being located downstream of said end portion and upstream of said outlet, said port having a chamber, an inlet to receive said first liquid from said tube and to deliver the first liquid to said chamber, an injection inlet via which a second liquid is delivered to said chamber, and an outlet providing for communication between said chamber and said burette for delivering the first and second liquid to said burette for delivery from the burette via said outlet as said outlet liquid.
Preferably, said injection inlet includes a closure operable to be opened for the delivery of said second liquid to said chamber but urged to a closed position closing said chamber.
Preferably, said injection port is connected to said burette by a further tube.
In an alternative preferred form, said injection port is mounted on said burette.
In a still further alternative form, said burette has a hollow body to receive the first and second liquids, and a upper part closing said body, with said injection port being incorporated in said upper part.
Preferably, said upper part includes a duct connected to said tube and in communication with said first inlet for the delivery of said first liquid to said chamber.
Preferred forms of the present invention will now be described by way of example with reference to the accompanying drawings wherein:
In the accompanying drawings there is schematically depicted various embodiments of a combination 10. Each combination 10 includes a burette 11. As an example, the burette 11 may be the burette described in International Patent Application PCT/AU2006/001495 (International Publication No. WO 2007/041787). The burette 11 may also be as per International Standard ISO 8536-5:2004. The burette 11 has an outer body 12 that extends to an outlet 13 from which a tube 14 extends to the patient, more particularly an intravenous tube. The upper portion 15 of the burette 11 includes a cap 16 sealingly engaged with the body 12. The cap 16 includes a port 17 closable by means of a plug 18 movably secured to the port 17. The cap 16 further includes a burette inlet 19 to which there is attached an injection port 20. The injection port 20 is also attached to a tube 21 extending to a reservoir 22. Typically the reservoir is a bag having a lower end into which there projects an end portion 23 of the tube 21. The end portion 23 has an inlet 24 via which a liquid contained in the reservoir 22 enters the tube 21 for delivery to the injection port 20. If required a clamp (not illustrated) may be applied to the tube 21 to regulate flow.
The injection port 20 includes an inlet in the form of an injection passage 25 via which a liquid is injected into the injection port 20. Typically the liquid being injected is a medication. The injection port 20 could be constructed substantially as described in U.S. Pat. No. 5,782,816, in particular an injection port as illustrated in
Located within the chamber enclosed by the body 26 is a movable closure member that is resiliently urged to close the passage 25. A male luer fitting is inserted in the passage 25 to displace the closure member to provide for the delivery of a liquid to the interior (chamber) of the body 12 for delivery to the burette 11. The male luer fitting may be in accordance with International Standard ISO 594-1:1986, preferably ISO 594-2:1998. To ensure all medication is delivered, a syringe having the luer fitting is operated to draw liquid in from within the body 12, this liquid would be in particular liquid from the reservoir 22. This is then again delivered to the interior of the body 12 by operation of the syringe. Accordingly, the syringe and injection port 20 are flushed with liquid from the reservoir 22. Liquids delivered via the inlet passage 25 and inlet 27 are then delivered to the patient via the outlet 13.
In the embodiment of
In the embodiment of
In the embodiment of
Number | Date | Country | Kind |
---|---|---|---|
2008903153 | Jun 2008 | AU | national |
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/AU2009/000550 | 4/30/2009 | WO | 00 | 12/20/2010 |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2009/152555 | 12/23/2009 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
3993066 | Virag | Nov 1976 | A |
4256103 | Mylrea | Mar 1981 | A |
4548600 | Ruschke | Oct 1985 | A |
20030018308 | Tsai | Jan 2003 | A1 |
Number | Date | Country |
---|---|---|
2413719 | Jan 2001 | CN |
1535638 | Jun 2005 | EP |
2104862 | Mar 1983 | GB |
8707158 | Dec 1987 | WO |
2009152555 | Dec 2009 | WO |
Entry |
---|
Chinese Office Action with translation dated Aug. 17, 2012, Application No. 200980121636.9, 16 pages. |
Number | Date | Country | |
---|---|---|---|
20110112485 A1 | May 2011 | US |